![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
19 min
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
Budesonide Oral Suspension Improves Outcomes in Eosinophilic Esophagitis Evidence-Based GI: An ACG Publication and Podcast
-
- Medicine
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Swathi Eluri, MD, MSCR discuss “Budesonide oral suspension improves outcomes in patients with eosinophilic esophagitis: results from a phase 3 trial,” by Hirano I, Collins MH, Katzka DA, et al. Clin Gastroenterol Hepatol. 2022 Mar;20(3):525-534.e10
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Swathi Eluri, MD, MSCR discuss “Budesonide oral suspension improves outcomes in patients with eosinophilic esophagitis: results from a phase 3 trial,” by Hirano I, Collins MH, Katzka DA, et al. Clin Gastroenterol Hepatol. 2022 Mar;20(3):525-534.e10
19 min